share_log

Artiva Biotherapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-venBio Global Strategic Fund III, L.P.(6.3%),venBio Global Strategic GP III, L.P.(6.3%), etc.

Artiva Biotherapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-venBio Global Strategic Fund III, L.P.(6.3%),venBio Global Strategic GP III, L.P.(6.3%)等

美股SEC公告 ·  2024/11/15 06:01
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息